Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. May 15, 2017; 9(5): 218-227
Published online May 15, 2017. doi: 10.4251/wjgo.v9.i5.218
Published online May 15, 2017. doi: 10.4251/wjgo.v9.i5.218
Variable | |
Sex, n (%) | |
Male | 16 (64) |
Female | 9 (36) |
Age, n (%) | Median, 61.9 yr (range, 30-72) |
ASA score, n (%) | I: 11 (44) |
II: 13 (52) | |
III: 1 (4) | |
Median, 2 | |
ECOG status | 0: 22 (88) |
1: 2 (8) | |
3: 1 (4) | |
Median, 0 | |
Co-morbidities, n (%) | |
Hypertension | 6 (24) |
Diabetes mellitus | 5 (20) |
Hyperlipidaemia | 8 (32) |
Ischaemic heart disease | 1 (4) |
Primary cancer type (n = 16) | |
Colorectal | 12 |
Chordoma | 3 |
Gynaecological | 1 |
Recurrent cancer type (n = 9) | |
Colorectal | 6 |
Gynaecological | 3 |
- Citation: Chew MH, Yeh YT, Toh EL, Sumarli SA, Chew GK, Lee LS, Tan MH, Hennedige TP, Ng SY, Lee SK, Chong TT, Abdullah HR, Goh TLH, Rasheed MZ, Tan KC, Tang CL. Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: The first 25 consecutive cases. World J Gastrointest Oncol 2017; 9(5): 218-227
- URL: https://www.wjgnet.com/1948-5204/full/v9/i5/218.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i5.218